Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Ramona | Durham | Series A | $25.0M | 2026-09-22 |
| Talus Bio | Seattle | Seed | $11.2M | 2026-09-21 |
| Samay | Mountain View | Seed | $350K | 2026-05-26 |
| Glyphic Biotechnologies | New York | Series A | $38.0M | 2025-09-26 |
| Terrestrial Bio | Cambridge | Series C | $50.0M | 2026-03-26 |
| Emulate | Boston | Series F | $47.1M | 2024-03-20 |
| Curi Bio | Seattle | Series B | $10.0M | 2025-12-02 |
| Epicore Biosystems | Cambridge | Series B | $6.0M | 2025-05-01 |
8 rows of the CSV in 5 of its 18 columns.
- The 32 National Institutes of Health portfolio companies have raised $1.4B in total.
- 5 of them closed their most recent round in the last 12 months, $96.5M combined.
- The largest of those rounds is Terrestrial Bio's $50.0M Series C, dated March 2026.
- The most recent is Ramona's $25.0M Series A on 22 September 2026.
- National Science Foundation is an investor in 8 of them, more than any other fund.
- Health care is the most common sector, with 31 companies (97%).
- 12% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (72% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
21 of 32| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Durham, United States | Series A | $25.0M | 2026-09-22 | $59.7M | National Science Foundation, National Institutes of Health, E14 Fund +1 | 11 to 50 | 2017 |
| Talus Bio | Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. | Artificial intelligence | Seattle, United States | Seed | $11.2M | 2026-09-21 | $27.8M | Y Combinator, Pioneer Fund, National Science Foundation +2 | 11 to 50 | 2020 |
| Samay | Samay develops an AI patch platform for diagnosing and managing COPD. | Artificial intelligence | Mountain View, United States | Seed | $350K | 2026-05-26 | $5.2M | National Institutes of Health, VentureWell | 11 to 50 | 2019 |
| Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Cambridge, United States | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
| Curi Bio | Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. | Artificial intelligence | Seattle, United States | Series B | $10.0M | 2025-12-02 | $30.4M | National Institutes of Health, Dynamk Capital | 11 to 50 | 2015 |
| South Rampart Pharma | South Rampart Pharma develops pain medications designed to reduce the risks of current treatments. | Biotech | New Orleans, United States | Series A | $8.0M | 2025-05-21 | $8.0M | National Institutes of Health | 1 to 10 | 2017 |
| Epicore Biosystems | Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. | Hardware | Cambridge, United States | Series B | $6.0M | 2025-05-01 | $41.9M | Alumni Ventures, National Institutes of Health, Joyance Partners +1 | 11 to 50 | 2017 |
| Biomotum | Biomotum builds wearable robotics for rehabilitation. | Hardware | Portland, United States | Seed | $290K | 2025-03-03 | $7.8M | National Institutes of Health, Remarkable, Bend Venture Conference +2 | 1 to 10 | 2019 |
| iotaMotion | IotaMotion develops robotics-assisted solutions for cochlear implant surgery. | Biotech | Saint Paul, United States | Series B | $6.4M | 2025-01-28 | $31.3M | National Science Foundation, National Institutes of Health, Next Level Ventures +2 | 11 to 50 | 2015 |
| Springbok Analytics | Springbok Analytics offers an AI platform that turns MRI scans into three-dimensional muscle analyses. | Artificial intelligence | Charlottesville, United States | Series A | $5.0M | 2025-01-24 | $11.2M | Alumni Ventures, National Science Foundation, National Institutes of Health +1 | 11 to 50 | 2013 |
| PhotoniCare | PhotoniCare develops diagnostic medical devices to improve clinical outcomes and meet unmet patient needs. | Health care | Champaign, United States | Series B | $4.6M | 2024-12-04 | $22.8M | National Science Foundation, Dreamit Ventures, MedTech Innovator +2 | 11 to 50 | 2013 |
| NextStep Robotics | NextStep Robotics develops a treatment for foot drop to help stroke survivors. | Artificial intelligence | Baltimore, United States | Seed | $200K | 2024-11-13 | $3.6M | TEDCO, National Institutes of Health, University System of Maryland Momentum Fund +1 | 11 to 50 | 2017 |
| Modality.AI | Modality.AI provides self-driven neurological assessments. | Artificial intelligence | San Francisco, United States | Seed | $571K | 2024-10-07 | $7.1M | Alchemist Accelerator, Creative Destruction Lab, National Institutes of Health +2 | 11 to 50 | 2018 |
| ONL Therapeutics | ONL Therapeutics develops biopharmaceuticals that protect photoreceptors to preserve vision. | Biotech | Ann Arbor, United States | Series D | $65.0M | 2024-09-13 | $147.9M | National Institutes of Health, Johnson & Johnson Innovation, Biosciences Research and Commercialization Center (BRCC) | 11 to 50 | 2011 |
| VenoStent | VenoStent develops bioabsorbable polymer wraps that improve outcomes in vascular surgery. | Biotech | Houston, United States | Series A | $4.0M | 2024-06-27 | $29.8M | Y Combinator, Alumni Ventures, National Science Foundation +2 | 11 to 50 | 2017 |
| Raydiant Oximetry | Raydiant Oximetry makes medical devices that improve outcomes for mothers and babies during childbirth. | Biotech | San Ramon, United States | Series A | $7.5M | 2024-06-04 | $25.6M | National Science Foundation, Enterprise Ireland, National Institutes of Health +1 | 11 to 50 | 2016 |
| Emulate | Emulate creates advanced in vitro models to study how diseases, medicines, and chemicals affect human health. | Biotech | Boston, United States | Series F | $47.1M | 2024-03-20 | $271.3M | Alumni Ventures, Qiming Venture Partners, National Institutes of Health | 51 to 100 | 2013 |
| Cytonus Therapeutics | Cytonus Therapeutics develops novel therapeutics using its proprietary drug delivery platform. | Artificial intelligence | Carlsbad, United States | Series A | $11.7M | 2023-11-03 | $20.9M | National Institutes of Health, Creative Ventures | 11 to 50 | 2018 |
| HealthRhythms | HealthRhythms builds a platform that assesses, monitors, and treats mental health conditions. | Artificial intelligence | Long Island City, United States | Seed | $11.0M | 2022-02-02 | $13.1M | MassChallenge, City Light Capital, National Institutes of Health +2 | 11 to 50 | 2014 |
| NovaSignal | NovaSignal commercializes a robotic system for cerebral ultrasound imaging. | Artificial intelligence | Los Angeles, United States | Series C | $37.0M | 2021-09-28 | $127.9M | MassChallenge, National Science Foundation, TCA Venture Group +2 | 51 to 100 | 2013 |
| HeartVista | HeartVista is a medical technology company that develops cardiac imaging software. | Artificial intelligence | Los Altos, United States | Series A | $8.7M | 2020-04-28 | $8.7M | Khosla Ventures, National Institutes of Health, Open Field Capital | 11 to 50 | 2012 |
Table 1. National Institutes of Health portfolio companies: the 21 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 32.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Cambridge, United States | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
| 2 | Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Durham, United States | Series A | $25.0M | 2026-09-22 | $59.7M | National Science Foundation, National Institutes of Health, E14 Fund +1 | 11 to 50 | 2017 |
| 3 | Talus Bio | Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. | Artificial intelligence | Seattle, United States | Seed | $11.2M | 2026-09-21 | $27.8M | Y Combinator, Pioneer Fund, National Science Foundation +2 | 11 to 50 | 2020 |
| 4 | Curi Bio | Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. | Artificial intelligence | Seattle, United States | Series B | $10.0M | 2025-12-02 | $30.4M | National Institutes of Health, Dynamk Capital | 11 to 50 | 2015 |
| 5 | Samay | Samay develops an AI patch platform for diagnosing and managing COPD. | Artificial intelligence | Mountain View, United States | Seed | $350K | 2026-05-26 | $5.2M | National Institutes of Health, VentureWell | 11 to 50 | 2019 |
Table 2. National Institutes of Health portfolio companies: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 8 | 25% | 2 | Ramona, Talus Bio |
| 2 | Alumni Ventures | Angel group | Manchester, United States | 6 | 19% | ||
| 3 | One North Carolina Small Business Program | Government investment office | Raleigh, United States | 2 | 6% | 1 | Ramona |
| 4 | Y Combinator | Startup accelerator | Mountain View, United States | 2 | 6% | 1 | Talus Bio |
| 5 | RA Capital Management | Startup incubator | Boston, United States | 2 | 6% | 1 | Terrestrial Bio |
| 6 | MassChallenge | Startup accelerator | Boston, United States | 2 | 6% | ||
| 7 | E14 Fund | Micro VC fund | Cambridge, United States | 1 | 3% | 1 | Ramona |
| 8 | Pioneer Fund | Startup accelerator | Toronto, Canada | 1 | 3% | 1 | Talus Bio |
| 9 | Fifty Years | Micro VC fund | San Francisco, United States | 1 | 3% | 1 | Talus Bio |
| 10 | VentureWell | Startup accelerator | Hadley, United States | 1 | 3% | 1 | Samay |
| 11 | stealthcap.com | Venture capital firm | New York, United States | 1 | 3% | ||
| 12 | Civilization Ventures | Venture capital firm | San Francisco, United States | 1 | 3% | ||
| 13 | Cantos | Micro VC fund | San Francisco, United States | 1 | 3% | ||
| 14 | The Engine | Venture capital firm | Cambridge, United States | 1 | 3% | 1 | Terrestrial Bio |
| 15 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 1 | 3% |
Table 3. National Institutes of Health portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 31 | 97% | $1.4B |
| Biotech | 20 | 62% | $1.3B |
| Software | 17 | 53% | $342.5M |
| Artificial intelligence | 12 | 38% | $319.4M |
| Hardware | 8 | 25% | $166.5M |
| Education | 1 | 3% | $500K |
Table 4. National Institutes of Health portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. National Institutes of Health portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| New York | 3 | 9% |
| Seattle | 2 | 6% |
| Cambridge | 2 | 6% |
| Boston | 2 | 6% |
| Durham | 1 | 3% |
| Mountain View | 1 | 3% |
| San Diego | 1 | 3% |
| Los Angeles | 1 | 3% |
| Charlottesville | 1 | 3% |
| Alameda | 1 | 3% |
| Long Island City | 1 | 3% |
| Charlestown | 1 | 3% |
Table 6. National Institutes of Health portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 2 | 40% | $36.2M |
| May 2026 | 1 | 20% | $350K |
| March 2026 | 1 | 20% | $50.0M |
| December 2025 | 1 | 20% | $10.0M |
Table 7. National Institutes of Health portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 12% | $86.5M |
| 2025 | 7 | 22% | $73.7M |
| 2024 | 12 | 38% | $176.9M |
| 2023 | 3 | 9% | $15.0M |
| 2022 | 1 | 3% | $11.0M |
| 2021 | 2 | 6% | $47.0M |
Table 8. National Institutes of Health portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 4 | 12% |
| 2015 to 2019 | 14 | 44% |
| 2010 to 2014 | 12 | 38% |
| Before 2010 | 2 | 6% |
Table 9. National Institutes of Health portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 6 | 19% |
| 11 to 50 | 23 | 72% |
| 51 to 100 | 2 | 6% |
| 101 to 250 | 1 | 3% |
Table 10. National Institutes of Health portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when National Institutes of Health is recorded as one of its investors. On 16 November 2026 that is 32 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 21 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 32 rows: 5 have no round amount, 0 no city and 0 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many National Institutes of Health portfolio companies are on the list?
- 32, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 32 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.